Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study
Ciarán P. Kelly, Joseph A. Murray, Daniel A. Leffler, et al.
Gastroenterology (2021) Vol. 161, Iss. 1, pp. 66-80.e8
Open Access | Times Cited: 138

Showing 51-75 of 138 citing articles:

Immunology in Celiac Disease
Eric Marietta, Rok Seon Choung, Alberto Rubio–Tapia, et al.
Gastrointestinal Endoscopy Clinics of North America (2025)
Closed Access
Zöliakie: Neue pharmakologische Therapien
Detlef Schuppan, Sibylle Neufang, Beate Wanger
DMW - Deutsche Medizinische Wochenschrift (2025) Vol. 150, Iss. 06, pp. 273-279
Closed Access
Celiac Disease—Narrative Review on Progress in Celiac Disease
Marek Kowalski, Danuta Domżał-Magrowska, Ewa Małecka‐Panas
Foods (2025) Vol. 14, Iss. 6, pp. 959-959
Open Access
Status and Influencing Factors of Post‐Intensive Care Syndrome‐Family Psychological Dysfunction of Geriatric Patients' Family Members: A Cross‐Sectional Study
Huihua Dong, Li Liu, Shasha Ma, et al.
Scandinavian Journal of Caring Sciences (2025) Vol. 39, Iss. 1
Closed Access
Cargo-less Nanoparticles Prevent Bone Loss in Periodontitis and Peri-implantitis
Muhammad H. A. Saleh, A. Roh, Kelly A. Martin, et al.
Journal of Dental Research (2025)
Closed Access
Nanoparticle platform preferentially targeting liver sinusoidal endothelial cells induces tolerance in CD4+ T cell-mediated disease models
Shu-Hung Wang, Isabelle Serr, Reinaldo Digigow, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
New Therapeutic Challenges in Pediatric Gastroenterology: A Narrative Review
Valeria Dipasquale, Claudio Romano
Healthcare (2025) Vol. 13, Iss. 8, pp. 923-923
Open Access
Immune therapies in coeliac disease and food allergies: Advances, challenges, and opportunities
Dianne E. Campbell, Sam Mehr, Olivia Moscatelli, et al.
Seminars in Immunology (2025) Vol. 78, pp. 101960-101960
Open Access
Harnessing Kupffer Cell Metabolic Rewiring: Rapamycin–Gliadin Nanoparticle as a Pivotal Strategy for Immune Tolerance in Celiac Disease
Xiaohan Jiang, Min Wang, Rui-han Zou, et al.
ACS Nano (2025)
Closed Access
Restoring immunological tolerance in established experimental arthritis by combinatorial citrullinated peptides and immunomodulatory signals
Xiaohong Chen, Guangsheng Du, Shuting Bai, et al.
Nano Today (2021) Vol. 41, pp. 101307-101307
Closed Access | Times Cited: 23
Tolerogenic Immune-Modifying Nanoparticles Encapsulating Multiple Recombinant Pancreatic β Cell Proteins Prevent Onset and Progression of Type 1 Diabetes in Nonobese Diabetic Mice
Joseph R. Podojil, Samantha Genardi, Ming‐Yi Chiang, et al.
The Journal of Immunology (2022) Vol. 209, Iss. 3, pp. 465-475
Open Access | Times Cited: 16
Ultrathin Niobium Carbide MXenzyme for Remedying Hypertension by Antioxidative and Neuroprotective Actions
Hui Yang, Lili Xia, Xuanxuan Ye, et al.
Angewandte Chemie (2023) Vol. 135, Iss. 26
Closed Access | Times Cited: 9
Potential therapeutic options for celiac Disease: An update on Current evidence from Gluten-Free diet to cell therapy
Effat Noori, Nader Hashemi, Delsuz Rezaee, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112020-112020
Closed Access | Times Cited: 3
Allergen‐Encapsulating Nanoparticles Reprogram Pathogenic Allergen‐Specific Th2 Cells to Suppress Food Allergy
Michael N. Saunders, Laila M. Rad, Laura A. Williams, et al.
Advanced Healthcare Materials (2024)
Open Access | Times Cited: 3
A bispecific antibody targeting HLA-DQ2.5-gluten peptides potently blocks gluten-specific T cells induced by gluten ingestion in patients with celiac disease
Melinda Y. Hardy, Lee Henneken, Amy K. Russell, et al.
Clinical Immunology (2024) Vol. 264, pp. 110259-110259
Open Access | Times Cited: 3
Antigen-specific immunotherapies for autoimmune disease
Jane H. Buckner
Nature Reviews Rheumatology (2024)
Closed Access | Times Cited: 3
Evolution of nanomedicines for the treatment of autoimmune disease: From vehicles for drug delivery to inducers of bystander immunoregulation
Yang Yang, Pere Santamaría
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113898-113898
Open Access | Times Cited: 18
Celiac disease and bone
Ananya Kondapalli, Marcella D. Walker
Archives of Endocrinology and Metabolism (2022) Vol. 66, Iss. 5, pp. 756-764
Open Access | Times Cited: 14
Nanomaterials for antigen-specific immune tolerance therapy
Jin-Won Park, Yina Wu, Qiaoyun Li, et al.
Drug Delivery and Translational Research (2022) Vol. 13, Iss. 7, pp. 1859-1881
Closed Access | Times Cited: 13
Delivery Route Considerations for Designing Antigen‐Specific Biomaterial Strategies to Combat Autoimmunity
Marian A. Ackun‐Farmmer, Christopher M. Jewell
Advanced NanoBiomed Research (2023) Vol. 3, Iss. 3
Open Access | Times Cited: 8
Engineering nanoparticle therapeutics for food allergy
Laila M. Rad, Gabriel Arellano, Joseph R. Podojil, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 3, pp. 549-559
Closed Access | Times Cited: 8
Cell and biomaterial delivery strategies to induce immune tolerance
Brianna L. Scotland, Jacob R. Shaw, Shruti Dharmaraj, et al.
Advanced Drug Delivery Reviews (2023) Vol. 203, pp. 115141-115141
Open Access | Times Cited: 8
Nanotargeted Delivery of Immune Therapeutics in Type 1 Diabetes
Sungwook Jung, Moufida Ben Nasr, Baharak Bahmani, et al.
Advanced Materials (2023) Vol. 35, Iss. 40
Closed Access | Times Cited: 7
Old and New Adjunctive Therapies in Celiac Disease and Refractory Celiac Disease: A Review
Marco Valvano, S. Fabiani, Sabrina Monaco, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12800-12800
Open Access | Times Cited: 7
PLG nanoparticles target fibroblasts and MARCO+ monocytes to reverse multiorgan fibrosis
Dan Xu, Swati Bhattacharyya, Wenxia Wang, et al.
JCI Insight (2022) Vol. 7, Iss. 5
Open Access | Times Cited: 12

Scroll to top